课题基金 / 基金详情

Conference-FASEB Growth Factor Receptor Tyrosine Kinases

Conference-FASEB Growth Factor Receptor Tyrosine Kinases
会议-FASEB生长因子受体酪氨酸激酶
批准号:
6774814
负责人:
William Muller
金额:
$0.9万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2008-07-31

项目摘要

项目成果

William Muller的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们寻求对FASEB夏季系列研究会议中的第三次会议的部分支持,该会议将于2003年8月2日至8月7日在亚利桑那州图森市举行,主题为“生长因子受体酪氨酸激酶I有丝分裂、形态发生和肿瘤发生”。 这次会议将建立在1999年和2001年举行的两次会议的成功,并继续集中在生物学和病理生理学的重要类别的生长因子受体酪氨酸激酶的新发展,因为它们涉及到有丝分裂,发展,形态发生,肿瘤发生和肿瘤进展。 由于酪氨酸激酶领域的压倒性的广度,与以前的会议一致,我们将保持一定的重点有关的ErbB和Met受体酪氨酸激酶家族的最新发展。 然而,关于发育系统的课程已经扩展到包括无脊椎动物受体信号传导范例,因为这些系统引领了对受体信号传导整合机制的理解。 对于这些和其他独特的受体激酶信号传导模式,我们将扩大范围超出这些受体。 一个新的会议,包括全体会议,已被添加到讨论的重要和热门问题的信号规范受体酪氨酸激酶。 科学计划将包括26位受邀演讲者的平台演讲,他们是各自领域的国际知名领导者。 该计划还将包括从摘要中选出的大量口头演讲,以及展示所有与会者工作的海报会议。 一个年轻的研究者小型研讨会,这是一个突出的前几次会议,将精选。 为了最大限度地提高与会者之间的科学互动,会议出席人数将限制在100-190名研究人员,包括受邀演讲者和从会议申请中选出的个人。 我们将奋进提供一个成熟的和初级调查人员的组合,并鼓励妇女和少数民族的参与。 我们预计,本次会议将成功地作为一个论坛,为国家的最先进的科学交流生长因子受体酪氨酸激酶。 它将促进新的合作企业,并保持适合FASEB会议系列的高标准。
英文摘要
DESCRIPTION (provided by applicant): We seek partial support for the third in a series of FASEB Summer Research Conferences on "Growth Factor Receptor Tyrosine Kinases I Mitogenesis, Morphogenesis, and Tumorigenesis", to be held in Tucson AZ from August 2 to August 7, 2003. This conference will build upon the success of the two earlier conferences held in 1999 and 2001, and continue to focus on new developments in biology and pathophysiology of important classes of growth factor receptor tyrosine kinases as they relate to mitogenesis, development, morphogenesis, tumorigenesis and tumor progression. Because of the overwhelming breadth of the tyrosine kinase field, consistent with earlier meetings we will maintain some emphasis on recent developments relevant to ErbB and Met families of receptor tyrosine kinases. However, the sessions on developmental systems have been expanded to include invertebrate receptor signaling paradigms, since these systems lead the way on understanding integrative mechanisms of receptor signaling. For these, and other unique receptor kinase signaling paradigms, we will broaden the scope beyond these receptors. A new session, including plenary talk, has been added to discuss the important and topical question of signal specification by receptor tyrosine kinases. The Scientific Program will include platform presentations by 26 invited speakers, internationally renowned leaders in their respective areas. The program will also include a significant number of oral presentations selected from the Abstracts, and also Poster Sessions to showcase work by all attendees. A Young Investigator Mini-Symposium, which was a highlight of the previous conferences, will be featured. In order to maximize scientific interactions among participants, conference attendance will be limited to 100-190 investigators including invited speakers and individuals selected from the conference applications. We will endeavor to provide a mix of established and junior investigators, with participation by women and minorities encourage. We anticipate that this conference will succeed in serving as a forum for state-of-the-art scientific interchange on growth factor receptor tyrosine kinases. It will foster new collaborative enterprises, and maintain the high standards appropriate to the FASEB Conference series.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of EGFR Family and Integrin Crosstalk in Breast Cancer Progression
Role of EGFR Family and Integrin Crosstalk in Breast Cancer Progression
Role of EGFR Family and Integrin Crosstalk in Breast Cancer Progression
Role of EGFR Family and Integrin Crosstalk in Breast Cancer Progression
海外基金